home / stock / ganx / ganx articles

GANX Articles, Gain Therapeutics Inc. - From 04/02/24

Stock Information
Company Name: Gain Therapeutics Inc.
Stock Symbol: GANX
Market: NASDAQ
Website: gaintherapeutics.com
Menu
GANX GANX Quote GANX Short GANX News GANX Articles GANX Message Board
Get GANX Alerts

News, Short Squeeze, Breakout and More Instantly...
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying | Benzinga

The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern arou...
Gain Therapeutics to Present at Public Ventures Discovery Day | Benzinga

BETHESDA, Md., March 15, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ:GANX) ("Gain", or the "Company"), a clinical-stage biotechnolo...

EXCLUSIVE: Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson's Disease | Benzinga

Gain Therapeutics Inc (NASDAQ:GANX) announces the presentation of a poster at the International Conference on Alzheimer’s and Parkinson&...

Gain Therapeutics Announces 2024 R&D Update on Parkinson's Disease with KOL & Analyst Insight | Benzinga

BETHESDA, Md., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (NASDAQ:GANX), a clinical-stage biotechnology company leading the disc...
Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research | Benzinga

BETHESDA, Md., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ:GANX) (the "Company"), a biotechnology company leading the disc...

Gain Therapeutics to Participate in AI Driven Drug Discovery Summit | Benzinga

BETHESDA, Md., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (NASDAQ:GANX), a clinical-stage biotechnology company leading the disc...

Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial re...
Gain Therapeutics Announces Pricing of $9.4 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants | Benzinga

BETHESDA, Md., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. ("Gain" or the "Company") (NASDAQ:GANX) today announced the pricing of...

Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023 | Benzinga

BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (NASDAQ:GANX) (the "Company"), a biotechnology company leading the dis...

Gain Therapeutics to Present at the Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets Conference | Benzinga

BETHESDA, Md., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (NASDAQ:GANX) ("Gain", or the "Company"), a biotechnology company lea...
Previous 10 Next 10